OraSure Technologies (NASDAQ:OSUR)is launching its at-home HIV diagnostic test in retail pharmacies, including CVS Caremark and Walgreen(NASDAQ:WBA). The company's share price increased during intra-day trading, and investors are waiting to see how well this product sells. OraSure is promoting the product through a massive marketing effort and will have support from a celebrity spokesperson.

In the following video, health-care analysts Max Macaluso and David Williamson discuss the potential impact of this marketing campaign on OraSure's sales and future stock performance.

OraSure will be an interesting stock to follow in the upcoming quarters, but are you looking to add other growth stocks to your portfolio? Our new report "Middle-Class Millionaire-Makers: 3 Stocks Wall Street's Too Rich to Notice" highlights three less-than-luxurious stocks the 1% may be overlooking. Just click here to read it today.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.